The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Related Posts
MongoDB plummets 20% as weak outlook overshadows strong quarterly results
MongoDB shares plummeted more than 20% after the database software maker shared weak guidance that signaled a slowdown in growth.
Morgan Stanley upgrades this chipmaker, sees it rallying more than 20%
Analyst Joseph Moore upgraded the stock to overweight from equal weight.
Stock futures tick lower as S&P 500 closes out second year in a row with 20% gain: Live updates
The S&P has surged more than 24% this year, on pace for its second consecutive annual gain above 20%.